Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Get up to date on 2024 wash sale rules for Dividend Etfs and how they affect harvesting strategies and reporting requirements.
15,526 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Oil jumps to $100 per barrel, sparking renewed interest in energy income strategies. This report breaks down XOMO, ML...
A blockbuster SpaceX IPO could reshape markets, but history shows the real winners are the infrastructure players beh...
Micron sits at the crossroads of AI demand, data-center spending, and cyclical memory trends. This guide explains why...
Bank America says long semiconductors have become the most crowded trade in history, a sign of feverish bets on AI ch...
NVIDIA is a marquee AI play, but there are smarter, more diversified ways to capture the AI infrastructure boom. This...
The latest CPI data gave a calm surface, but the big questions remain. Wednesday's report didn't solve the inflation ...
When mood is grim, many wonder if it’s time to abandon stocks. History says the market often bounces back; smart, dis...
Tech stocks just their footing as an AI spending surge loses steam. The sector faced a rough week, driven by slower d...
Investors face a 28% price return gap between XYLD and SPY as income-focused strategy meets growth potential. This re...
As the S&P 500 sits near record highs, leadership is shifting toward defensive names. This article explains why consu...
A bold bet on a geothermal energy company highlights a broader shift in the renewable energy stock year. Learn what i...